Evidence for a proliferative advantage of human leukemia colony forming cells in vitro

Hal Broxmeyer, E. Grossbard, N. Jacobsen, M. A S Moore

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Inhibitory mechanisms that might provide leukemia granulocytic stem cells with a proliferative advantage over normal granulocytic stem cells were investigated. Extracts from marrow and blood cells of patients with leukemia were assayed for inhibitory activity against the exogenously stimulated cloning of normal and leukemia granulocyte-monocyte colony-forming cells in agar (CFU-C) present in fractions of nonadherent light density bone marrow. Extracts of cells from patients who had acute leukemia not in remission and who had inhibitory activity-containing cells had higher levels of inhibitory activity against normal CFU-C than did extracts from cells of patients who had chronic leukemia. Extracts from normal cells did not inhibit exogenously stimulated normal or leukemia colony formation. Leukemia CFU-C were unaffected by single or multiple additions of leukemia cell extracts containing 104-106 times as much inhibitory activity as that necessary for maximal inhibition of CFU-C from normal donors. Cells from patients with acute leukemia in remission rarely demonstrated inhibitory activity. However, CFU-C from most of these patients with acute leukemia in remission were insensitive to active leukemia cell extracts. The cell responsible for inhibitory activity against normal CFU-C was nonadherent and of light density and had a velocity sedimentation range of 2.5-6.3 mm/hour. The number and percent of cells containing inhibitory activity varied from patient to patient but appeared to be higher in patients with more aggressive disease. Inhibitory cells could be partially separated from CFU-C of leukemia patients. These in vitro phenomena may have relevance to the pathogenesis of acute leukemia.

Original languageEnglish (US)
Pages (from-to)513-521
Number of pages9
JournalJournal of the National Cancer Institute
Volume60
Issue number3
StatePublished - 1978
Externally publishedYes

Fingerprint

Leukemia
Cell Extracts
In Vitro Techniques
Stem Cells
Bone Marrow
Light
Myeloid Leukemia
Granulocytes
Agar
Organism Cloning
Monocytes
Blood Cells
Cell Count
Tissue Donors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Evidence for a proliferative advantage of human leukemia colony forming cells in vitro. / Broxmeyer, Hal; Grossbard, E.; Jacobsen, N.; Moore, M. A S.

In: Journal of the National Cancer Institute, Vol. 60, No. 3, 1978, p. 513-521.

Research output: Contribution to journalArticle

Broxmeyer, Hal ; Grossbard, E. ; Jacobsen, N. ; Moore, M. A S. / Evidence for a proliferative advantage of human leukemia colony forming cells in vitro. In: Journal of the National Cancer Institute. 1978 ; Vol. 60, No. 3. pp. 513-521.
@article{39cd8cdc55754e7d98191e33801af50a,
title = "Evidence for a proliferative advantage of human leukemia colony forming cells in vitro",
abstract = "Inhibitory mechanisms that might provide leukemia granulocytic stem cells with a proliferative advantage over normal granulocytic stem cells were investigated. Extracts from marrow and blood cells of patients with leukemia were assayed for inhibitory activity against the exogenously stimulated cloning of normal and leukemia granulocyte-monocyte colony-forming cells in agar (CFU-C) present in fractions of nonadherent light density bone marrow. Extracts of cells from patients who had acute leukemia not in remission and who had inhibitory activity-containing cells had higher levels of inhibitory activity against normal CFU-C than did extracts from cells of patients who had chronic leukemia. Extracts from normal cells did not inhibit exogenously stimulated normal or leukemia colony formation. Leukemia CFU-C were unaffected by single or multiple additions of leukemia cell extracts containing 104-106 times as much inhibitory activity as that necessary for maximal inhibition of CFU-C from normal donors. Cells from patients with acute leukemia in remission rarely demonstrated inhibitory activity. However, CFU-C from most of these patients with acute leukemia in remission were insensitive to active leukemia cell extracts. The cell responsible for inhibitory activity against normal CFU-C was nonadherent and of light density and had a velocity sedimentation range of 2.5-6.3 mm/hour. The number and percent of cells containing inhibitory activity varied from patient to patient but appeared to be higher in patients with more aggressive disease. Inhibitory cells could be partially separated from CFU-C of leukemia patients. These in vitro phenomena may have relevance to the pathogenesis of acute leukemia.",
author = "Hal Broxmeyer and E. Grossbard and N. Jacobsen and Moore, {M. A S}",
year = "1978",
language = "English (US)",
volume = "60",
pages = "513--521",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Evidence for a proliferative advantage of human leukemia colony forming cells in vitro

AU - Broxmeyer, Hal

AU - Grossbard, E.

AU - Jacobsen, N.

AU - Moore, M. A S

PY - 1978

Y1 - 1978

N2 - Inhibitory mechanisms that might provide leukemia granulocytic stem cells with a proliferative advantage over normal granulocytic stem cells were investigated. Extracts from marrow and blood cells of patients with leukemia were assayed for inhibitory activity against the exogenously stimulated cloning of normal and leukemia granulocyte-monocyte colony-forming cells in agar (CFU-C) present in fractions of nonadherent light density bone marrow. Extracts of cells from patients who had acute leukemia not in remission and who had inhibitory activity-containing cells had higher levels of inhibitory activity against normal CFU-C than did extracts from cells of patients who had chronic leukemia. Extracts from normal cells did not inhibit exogenously stimulated normal or leukemia colony formation. Leukemia CFU-C were unaffected by single or multiple additions of leukemia cell extracts containing 104-106 times as much inhibitory activity as that necessary for maximal inhibition of CFU-C from normal donors. Cells from patients with acute leukemia in remission rarely demonstrated inhibitory activity. However, CFU-C from most of these patients with acute leukemia in remission were insensitive to active leukemia cell extracts. The cell responsible for inhibitory activity against normal CFU-C was nonadherent and of light density and had a velocity sedimentation range of 2.5-6.3 mm/hour. The number and percent of cells containing inhibitory activity varied from patient to patient but appeared to be higher in patients with more aggressive disease. Inhibitory cells could be partially separated from CFU-C of leukemia patients. These in vitro phenomena may have relevance to the pathogenesis of acute leukemia.

AB - Inhibitory mechanisms that might provide leukemia granulocytic stem cells with a proliferative advantage over normal granulocytic stem cells were investigated. Extracts from marrow and blood cells of patients with leukemia were assayed for inhibitory activity against the exogenously stimulated cloning of normal and leukemia granulocyte-monocyte colony-forming cells in agar (CFU-C) present in fractions of nonadherent light density bone marrow. Extracts of cells from patients who had acute leukemia not in remission and who had inhibitory activity-containing cells had higher levels of inhibitory activity against normal CFU-C than did extracts from cells of patients who had chronic leukemia. Extracts from normal cells did not inhibit exogenously stimulated normal or leukemia colony formation. Leukemia CFU-C were unaffected by single or multiple additions of leukemia cell extracts containing 104-106 times as much inhibitory activity as that necessary for maximal inhibition of CFU-C from normal donors. Cells from patients with acute leukemia in remission rarely demonstrated inhibitory activity. However, CFU-C from most of these patients with acute leukemia in remission were insensitive to active leukemia cell extracts. The cell responsible for inhibitory activity against normal CFU-C was nonadherent and of light density and had a velocity sedimentation range of 2.5-6.3 mm/hour. The number and percent of cells containing inhibitory activity varied from patient to patient but appeared to be higher in patients with more aggressive disease. Inhibitory cells could be partially separated from CFU-C of leukemia patients. These in vitro phenomena may have relevance to the pathogenesis of acute leukemia.

UR - http://www.scopus.com/inward/record.url?scp=0018133026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018133026&partnerID=8YFLogxK

M3 - Article

C2 - 625061

AN - SCOPUS:0018133026

VL - 60

SP - 513

EP - 521

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3

ER -